Ernexa Therapeutics Inc.: Form 8-K, filed Jun 17, 2022
Filed with the SEC on Jun 17, 2022 and accepted by EDGAR at Jun 17, 2022, 17:21 ET.
Items reported
- Item 3.01 Delisting notice
- Item 4.02 Non-reliance on financial statements
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-22-023519. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.